Lansforsakringar Fondforvaltning’s Edwards Lifesciences EW Stock Holding History

Lansforsakringar Fondforvaltning’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$15.1M	Sell	188,318 -1,078	-0.6%	-$88.9K	0.08%	207
2025 Q4	$16.1M	Sell	189,396 -83,927	-31%	-$6.89M	0.08%	196
2025 Q3	$21.3M	Buy	273,323 +10,747	+4%	+$840K	0.11%	158
2025 Q2	$20.5M	Sell	262,576 -18,295	-7%	-$1.36M	0.12%	155
2025 Q1	$20.4M	Sell	280,871 -15,846	-5%	-$1.13M	0.12%	149
2024 Q4	$22M	Buy	+296,717	New	+$20.8M	0.12%	142

Other funds holding EW

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Lansforsakringar Fondforvaltning's EW Position: Q1 2026 in Review

Lansforsakringar Fondforvaltning reduced its Edwards Lifesciences (EW) stake by 0.57% in Q1 2026, selling an estimated $88.9K and leaving 188,318 shares worth $15.1M. The position accounts for 0.08% of the portfolio, ranked #207.

Lansforsakringar Fondforvaltning first reported a position in EW in Q4 2024 and has held it in 6 quarters since. The position peaked at $22M in Q4 2024. 1,284 funds tracked by Wall St. Rank hold EW as of Q1 2026.

Lansforsakringar Fondforvaltning held 188,318 shares of Edwards Lifesciences worth $15.1M as of Q1 2026.
Lansforsakringar Fondforvaltning sold 1,078 Edwards Lifesciences shares in Q1 2026, an estimated $88.9K.
Edwards Lifesciences made up 0.08% of Lansforsakringar Fondforvaltning's portfolio in Q1 2026, its #207 holding.
Lansforsakringar Fondforvaltning first reported a position in Edwards Lifesciences in Q4 2024 and has held it in 6 quarters since.
Lansforsakringar Fondforvaltning's Edwards Lifesciences position peaked at $22M in Q4 2024.
1,284 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.

Based on Lansforsakringar Fondforvaltning's 13F filing for Q1 2026, filed 23 Apr 2026.